Ki-67 immunoreactivity, ploidy and s-phase fraction as prognostic factors in patients with gastric carcinoma

Oncology (Switzerland)

Volumn 53, Issue 3, 1996, Pages 182-191

  Victorzon, M ^a   Victorzon, P J ^a   Haglund, C ^a   von Boguslawsky, K ^a   Nordling, S ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

DNA ploidy; Flow cytometry; Gastric neoplasms; Immunoreactivity; Ki 67; S phase fraction

Indexed keywords

CELL NUCLEUS ANTIGEN; DNA; MONOCLONAL ANTIBODY KI 67; PARAFFIN;

ADULT; AGED; ANEUPLOIDY; ANTIGEN EXPRESSION; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE S PHASE; DNA DETERMINATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; STATISTICAL ANALYSIS; STOMACH CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; DNA, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PLOIDIES; PROGNOSIS; S PHASE; STOMACH NEOPLASMS;

EID: 0029962429     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000227558     Document Type: Article

References (42)

1. Hedlcy DW, Fricdlandcr ML, Taylor IW, Rugg CA, Musgrove HA: Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry, J Histochcm Cytochem 1983;31:1333-1335.
2. Gcrdcs J, Schwab U, Lemke H, Stein H: Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation, Int J Cancer 1983.31: 13-20.
3. Brown DC, Gatter KC: Monoclonal antibody Ki-67: Its use in histopathology, llistopathology 1990:17:489-503.
4. Stenfert-Krocse M, Rutgers D, Wils I, Van Un-nik J, Roholi P: The relevance of the DNA index and proliferation rate in the grading of benign and malignant soft tissue tumours, Cancer 1990:65:1782-1788.
5. Swanson SA, Brooks JJ: Proliferation markers Ki-67 and pl05 in soft-tissuc lesions, Correlation with DNA flow cytometric characteristics, Am J Pathol 1990;137:1491-1500.
6. Look T, Hayes F, Nitschke R, McWilliams N, Green A: Cellular DNA content as a predictor of response to chemotherapy in infants with unrcscctable neuroblastoma, N Engl J Med 1984;311:231-235.
7. Merkel DE, McGuire WL: Ploidy, proliferative activity and prognosis, DNA flow cytometry of solid tumors, Cancer 1990:65:1194-1205.
8. Sigurdsson H, Baldctorp B, Borg A, Dalberg M, Fcrno M, Killander D, Olsson H: Indicators of prognosis in node-negative breast cancer (sec comments), N Engl J Med 1990:322:1045- 1053.
9. Yonemura Y, Ooyama S, Sugiyama K, Kamata T, De Aretxabala X, Kimura H, Kosaka T, Yamaguchi A, Miwa K, Miyazaki I: Retrospective analysis of the prognostic significance of DNA ploidy patterns and S-phase fraction in gastric carcinoma, Cancer Res 1990:50:509-514.
10. Camplejohn RS, Ash CM, Gillett CE, Raikun-dalia B, Barnes DM, Gregory' WM, Richards MA, Millis RR: The prognostic significance of DNA flow cytometry in breast cancer: Results from 881 patients treated in a single centre, Br J Cancer 1995:71:140-145.
11. Nanus D, Kelsen D, Niedzwiecki D, Chapman D, Brennan M, Cheng E, et al: Flow cytometry as a predictive indicator in patients with operable gastric cancer, J Clin Oncol 1989:7:1105-1112.
12. Wyatt J, Quirke P, Ward D, Clayden A, Dixon M, Johnson D, ct al: Comparison of histopath-ological and flow cytometric parameters in prediction of prognosis in gastric cancer, 1 Pathol 1989:158:195-201.
13. Flyger II, Christensen I, Thorup J, Hakansson T, Norgaard T: DNA aneuploidy in gastric carcinoma, Scand J Gastroenterol 1995:30:258- 264.
14. Hattori T, Hosokawa Y, Fukda M, Sugihara H, Hamada S, Tamkamatsu T, et al: Analysis of DNA ploidy patterns of gastric carcinomas of Japanese, Cancer 1984:54:1591 - 1597.
15. Macartney JC, Camplejohn RS, Powell G: DNA flow cytometry of histological material from human gastric cancer, J Pathol 1986:148: 273-277.
16. Ballantync K, James P, Robins R, Baldwin R, Hardcastle J: Flow cytometric analysis of the DNA content of gastric cancer, Br J Cancer 1987;56:52-54.
17. Filipe M, Rosa J, Sandey A, ct al: Is DNA ploidy and proliferative activity of prognostic value in advanced gastric carcinoma? Hum Pathol 1991:22:373-378.
18. Schwarting R: Little missed markers and Ki-67 (editorial), Lab Invest 1993:68:597-599.
19. UICC: TNM Classification of Malignant Tumors, ed 4. Berlin, Springer, 1987.
20. Lauren P: The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinomas: An attempt at a histological classification, Acta Pathol Microbiol Scand 1965:64:31-49.
21. Cox DR: Regression models and life tables, J R StatSoc 1972:34:187-220.
22. Gerdcs J, Lemke II, Baisch H, Wacker HH, Schwab U, Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984:133:1710-1715.
23. Strang P, Eklund G, Stendahl U, Frankendal B: S-phase rate as a predictor of early recurrences in carcinoma of the uterine cervix, Anticancer Res 1987:7:807-810.
24. Sadi MV, Barrack ER: Determination of growth fraction in advanced prostate cancer by Ki-67 immunostaining and its relationship to the time to tumor progression after hormonal therapy, Cancer 1991;67:3065-3071.
25. Tungckar MF, Gatter KC, Dunnill MS, Mason DY: Ki-67 immunostaining and survival in operable lung cancer, Histopathology 1991:19: 545-550.
26. Drach J, Gattringer C, Glassl H, Drach D, Huber H: The biological and clinical significance of the Ki-67 growth fraction in multiple myebma, Hematol Oncol 1992; 10:125- 134.
27. Smolle J, Hofmann-Wellcnhof R, Kerl H: Prognostic significance of proliferation and motility in primary malignant melanoma of the skin, J Cutan Pathol 1992; 19:110-115.
28. Yamanaka N, Harabuchi Y, Kataura A: The prognostic value of Ki-67 antigen in non-Hodg-kin lymphoma of Waldcyer ring and the nasal cavity, Cancer 1992;70:2342-2349.
29. Veronese SM, Gambacorta M, Gottardi O, Scanzi F, Ferrari M, Lampertico P: Proliferation index as a prognostic marker in breast cancer, Cancer 1993;71:3926-3931.
30. Kakeji Y, Maehara Y, Adachi Y, Baba H, Mori M, Furusawa M, Sugimachi K: Proliferative activity as a prognostic factor in Borrmann type 4 gastric carcinoma, Br J Cancer 1994:69: 749-753.
31. Dclahunt B, Bethwaite P, Thornton A, Ribase J: Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labeling, C ancer 1995:75:2714-2719.
32. Brown D, Cole D, Gatter K, Mason D: Carcinoma of the cervix uteri: An assessment of tumour proliferation using the monoclonal antibody Ki-67. Br J Cancer 1988;57:178-181.
33. Weiss L, Strickler J, Medeiros L, Gerdes J, Stein H: Proliferative rates of non-Hodgkin lymphomas as assessed by Ki-67 antibody, Hum Pathol 1987; 18:1 155-1159.
34. Gatter KC, Dunnill MS, Gerdes J, Stein H, Mason DY: New approach to assessing lung tumours in man, J Clin Pathol 1986:39:590-593.
35. Kakeji Y, Korenaga D, Tsujitani S, Haraguchi M, Maehara Y, Sugimachi K: Predictive value of Ki-67 and argyrophilic nucleolar organizer region staining for lymph node metastasis in gastric cancer, Cancer Res 1991:51:3503-3506.
36. Hemming A, Davis N, Kluftinger A, Robinson B, Quenville N, Liseman B, LeRiche J: Prognostic markers of colorectal cancer: An evaluation of DNA content, epidermal growth factor receptor and KI-67. J Surg Oncol 1992:51:147- 152.
37. Kubota Y, Pctras R, Easley K, Bauer T, Tubbs R, Fazio V: Ki-67 determined growth fraction versus standard staging and grading parameters in colorectal carcinoma, A multivariate analysis, Cancer 1992:70:2602-2609.
38. Schwartz B, Pinkus G, Bacus S, Toder M, Weinberg D: Cell proliferation in non-Hodgkin lymphomas, Digital image analysis of Ki-67 antibody staining, Am J Pathol 1989; 134:327- 336.
39. Yonemura Y, Ohoyama S, Kimura H, Matu-moto H, Nonimiya I, Kosaka T, Yamaguchi A, Miwa K, Miyazaki I: Independent clinical and flow cytometric prognostic factors for the survival of patients with stage I gastric cancer, Surg Today 1992;22:416-420.
40. Lee K, Lee 3. Suh C, Ahn M, Kim S, Doh B, Min Y, Kim B, Park K, Lee 1. Cho Y, Choi M, Kim S: DNA flow cytometry of stomach cancer, Cancer 1993;72:1819-1826.
41. Umehara Y, Kimura T, Yoshida M, Oba N, Harada Y: Heterogeneity in early and advanced gastric carcinomas by flow cytometric DNA analysis, J Surg Oncol 1993;52:97-100.
42. Johnson H, Belluco C, Masood S, Abou-Azama A, Kahn L, Wise L: The value of flow cytometric analysis in patients with gastric cancer, Arch Surg 1993;128:314-317